PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22029653-8	2012	CD56 expression (a marker for cytotoxic cells) was lower on zoledronate-expanded cells, consistent with significantly lower cytotoxicity against the Daudi tumor cell line.	Zoledronic Acid	60-71	neural cell adhesion molecule 1	Homo sapiens	0-4	
25363560-7	2015	In contrast to mIL-4DCs, the CD56(high+) IFN-DCs exhibited a stronger capacity to stimulate autologous CD56+ Vgamma9gammadeltaT cells highly producing IFNgamma in the presence of zoledronate and IL-2.	Zoledronic Acid	179-190	neural cell adhesion molecule 1	Homo sapiens	29-33	
25363560-7	2015	In contrast to mIL-4DCs, the CD56(high+) IFN-DCs exhibited a stronger capacity to stimulate autologous CD56+ Vgamma9gammadeltaT cells highly producing IFNgamma in the presence of zoledronate and IL-2.	Zoledronic Acid	179-190	neural cell adhesion molecule 1	Homo sapiens	103-107	
25363560-8	2015	The CD56(high+) IFN-DCs possessing HLA-A*0201 effectively induced Mart-1-modified melanoma peptide (A27L)-specific CD8+ T cells through preferential expansion of CD56+ Vgamma9gammadeltaT cells in the presence of A27L, zoledronate and IL-2.	Zoledronic Acid	218-229	neural cell adhesion molecule 1	Homo sapiens	4-8	
25363560-9	2015	Vaccination with CD56(high+) IFN-DCs copulsed with tumor antigens and zoledronate may orchestrate the induction of various CD56+ immune cells possessing high effector functions, resulting in strong immunological responses against tumor cells.	Zoledronic Acid	70-81	neural cell adhesion molecule 1	Homo sapiens	17-21	
25363560-9	2015	Vaccination with CD56(high+) IFN-DCs copulsed with tumor antigens and zoledronate may orchestrate the induction of various CD56+ immune cells possessing high effector functions, resulting in strong immunological responses against tumor cells.	Zoledronic Acid	70-81	neural cell adhesion molecule 1	Homo sapiens	123-127	
19762486-3	2009	Stimulation of CD56+ cells containing both DCs and abundant gammadelta T cells with zoledronate and interleukin-2 (IL-2) resulted in the rapid expansion of gammadelta T cells as well as in IFN-gamma, TNF-alpha, and IL-1beta but not in IL-4, IL-10, or IL-17 production.	Zoledronic Acid	84-95	neural cell adhesion molecule 1	Homo sapiens	15-19	
21673342-2	2011	Using IL-2-primed cultures of CD56(+) peripheral blood mononuclear cells, we show here that zoledronic acid (zoledronate) could induce IFN-gamma production not only in gammadelta T lymphocytes but, surprisingly, also in natural killer (NK) cells in a manner that depended on antigen-presenting cells, which share properties of inflammatory monocytes and dendritic cells (DCs; here referred to as DC-like cells).	Zoledronic Acid	92-107	neural cell adhesion molecule 1	Homo sapiens	30-34	
21673342-2	2011	Using IL-2-primed cultures of CD56(+) peripheral blood mononuclear cells, we show here that zoledronic acid (zoledronate) could induce IFN-gamma production not only in gammadelta T lymphocytes but, surprisingly, also in natural killer (NK) cells in a manner that depended on antigen-presenting cells, which share properties of inflammatory monocytes and dendritic cells (DCs; here referred to as DC-like cells).	Zoledronic Acid	109-120	neural cell adhesion molecule 1	Homo sapiens	30-34	
34306272-5	2021	The count of CD3+T cells, CD3+CD4+T cells, and CD16+CD56+ natural killer lymphocytes decreased from day 1 to day 3 after the first and second zoledronic acid infusion, but the results of second infusion showed no significance.	Zoledronic Acid	142-157	neural cell adhesion molecule 1	Homo sapiens	52-56